4.7 Article

Temporal Trends in Infective Endocarditis in the Context of Prophylaxis Guideline Modifications Three Successive Population-Based Surveys

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 59, Issue 22, Pages 1968-1976

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2012.02.029

Keywords

epidemiology; infective endocarditis; population-based; prophylaxis; staphylococci

Funding

  1. L'Association Pedagogique Nationale pour l'Enseignement de la Therapeutique
  2. Societe de Pathologie Infectieuse de Langue Francaise
  3. Societe Francaise de Microbiologie
  4. Societe Nationale Francaise de Medecine Interne
  5. Societe de Reanimation de Langue Francaise
  6. Societe Francaise de Gerontologie
  7. Societe Francaise de Cardiologie
  8. Societe Francaise de Chirurgie Thoracique et Cardiovasculaire
  9. Societe Francaise d'Anesthesie-Reanimation
  10. Federation Francaise de Cardiologie
  11. Inserm network on infective endocarditis
  12. French Ministry of Health
  13. European Society of Clinical Microbiology and Infectious Diseases
  14. Novartis Laboratories
  15. Departement a la Recherche Clinique et a l'innovation (French Ministry of Health), Hopital Universitaire de Besancon
  16. Edwards Lifesciences
  17. Sanofi-Aventis

Ask authors/readers for more resources

Objectives The goal of this study was to evaluate temporal trends in infective endocarditis (IE) incidence and clinical characteristics after 2002 French IE prophylaxis guideline modifications. Background There are limited data on changes in the epidemiology of IE since recent guidelines recommended restricting the indications of antibiotic prophylaxis of IE. Methods Three 1-year population-based surveys were conducted in 1991, 1999, and 2008 in 3 French regions totaling 11 million inhabitants age >= 20 years. We prospectively collected IE cases from all medical centers and analyzed age-and sex-standardized IE annual incidence trends. Results Overall, 993 expert-validated IE cases were analyzed (323 in 1991; 331 in 1999; and 339 in 2008). IE incidence remained stable over time (95% confidence intervals given in parentheses/brackets): 35 (31 to 39), 33 (30 to 37), and 32 (28 to 35) cases per million in 1991, 1999, and 2008, respectively. Oral streptococci IE incidence did not increase either in the whole patient population (8.1 [6.4 to 10.1], 6.3 [4.8 to 8.1], and 6.3 [4.9 to 8.0] in 1991, 1999, and 2008, respectively) or in patients with pre-existing native valve disease. The increased incidence of Staphylococcus aureus IE (5.2 [3.9 to 6.8], 6.8 [5.3 to 8.6], and 8.2 [6.6 to 10.2]) was not significant in the whole patient population (p = 0.228) but was significant in the subgroup of patients without previously known native valve disease (1.6 [0.9 to 2.7], 3.7 [2.6 to 5.1], and 4.1 [3.0 to 5.6]; p = 0.012). Conclusions Scaling down antibiotic prophylaxis indications was not associated with an increased incidence of oral streptococcal IE. A focus on avoidance of S. aureus bacteremia in all patients, including those with no previously known valve disease, will be required to improve IE prevention. (J Am Coll Cardiol 2012; 59: 1968-76) (C) 2012 by the American College of Cardiology Foundation

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available